FilingFirehose · free AI preview
Hepion Pharmaceuticals, Inc.
HEPA · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Hepion Pharmaceuticals (HEPA) reported an officer departure via 8-K filing on April 14, 2026, with no cyber incidents detected in the past 90 days. This isolated personnel change warrants context—understanding the departing role, timing relative to clinical milestones, and any underlying governance shifts. The full $49 Report adds our dilution risk score, complete 8-K context with officer titles and circumstances, 12-month financing and capital structure history, and AI-detected risk signals across SEC filings.
Want the full 5-section $49 Report on HEPA?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.